Lin Fang
5268 Remin Street
Changchun, 130024, China
Changchun, 130024, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Presence of drug-drug interactions between esomeprazole and an ALK tyrosine kinase inhibitor (Dirozalkib).
Journal: Cancer chemotherapy and pharmacology
Published: June 22, 2025
Safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-2010, a novel anti-MASP-2 antibody, in healthy volunteers: a randomized, double-blind, placebo-controlled phase 1 study.
Journal: Expert opinion on investigational drugs
Published: April 29, 2025
Efficacy and safety of PEGylated uricase in healthy adults and patients with hyperuricaemia: A phase I, randomized, double-blind, dose-escalation, placebo-controlled trial.
Journal: Diabetes, obesity & metabolism
Published: February 24, 2025
Observation of the efficacy and safety of obinutuzumab in the treatment of refractory idiopathic membranous nephropathy.
Journal: International urology and nephrology
Published: November 18, 2024
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial.
Journal: Med (New York, N.Y.)
Published: November 13, 2024
Tumor aggression-defense index-a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer.
Journal: Journal of translational medicine
Published: September 18, 2024
Multiomics Reveals the Immunologic Features and the Immune Checkpoint Blockade Potential of Colorectal Medullary Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 01, 2024
Efficacy and safety of immune checkpoint inhibitors in solid tumor patients combined with chronic coronary syndromes or its risk factor: a nationwide multicenter cohort study.
Journal: Cancer immunology, immunotherapy : CII
Published: May 05, 2024
Smad4 deficiency inhibits lung metastases through enhancing phagocytosis of lung interstitial macrophages.
Journal: Biochemical and biophysical research communications
Published: April 09, 2024
Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors.
Journal: Expert review of clinical immunology
Published: March 09, 2024
Novel biomarkers related to oxidative stress and immunity in chronic kidney disease.
Journal: Heliyon
Published: February 27, 2024
Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD-mediated pyroptosis in colorectal cancer.
Journal: Clinical and translational medicine
Published: December 26, 2023
Last Updated: 09/26/2026